Most-recognized central nervous system brands
The most-recognized central
nervous system brand in the United States and Europe is Prozac. The product
was recognized by 31.1% of U.S. physicians in a survey conducted by Brand Institute
Inc. in the second quarter of 2003. In Europe, 16.7% of physicians recognize
the brand. Prozac is marketed by Eli Lilly and Co. (lilly.com). Prozac is indicated
for the treatment of depression, obsessive-compulsive disorder, panic disorder,
and bulimia, including long-term treatment.
The second most-recognized central nervous system product in the United States
is Zoloft, known by 18.1% of physicians surveyed by Brand Institute. Zoloft
is marketed by Pfizer Inc. (pfizer.com). Zoloft is a prescription medicine indicated
for the treatment of depression, panic disorder, obsessive-compulsive disorder,
and post-traumatic stress disorder in adults. Zoloft additionally is indicated
for the treatment of obsessive-compulsive disorder in children and adolescents.
The third most-recognized central nervous system brand in the United States is Paxil by 13.4% of physicians. Paxil is marketed by GlaxoSmithKline (gsk.com). Paxil is indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and post-traumatic stress disorder.
Valium is the second most-recognized central nervous system and mental-health brand in Europe by 10.2% of physicians. Valium is indicated for the treatment of anxiety disorders. Roche (roche.com) is the marketer of Valium.
Tavor is the third most-recognized central nervous system brand in Europe by 5.6% of physicians. Tavor is marketed in Europe by Wyeth (wyeth.com). In the United States, the active chemical in Tavor, lorazepam, is marketed as Ativan by Biovail Corp. (biovail.com). Biovail acquired the U.S. rights to Ativan from Wyeth in June. Ativan is indicated for the treatment of anxiety disorders, for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms, in adult patients for preanesthetic medication, and for the treatment of status epilepticus.
Brand Institute (brandinstitute.com)
surveyed more than 2,000 medical professionals in NorthAmerica and Europe to
determine the most-recognizable brands in the central nervous system and mental-health
category. The Brandpoll.com sample consists of physicians and hospital and retail
pharmacists. Brandpoll is a marketing tool designed by Brand Institute to help
clients monitor the competitive marketplace and identify potential strengths
and weakness of their brands.
Brand Names
